openPR Logo
Press release

Borderline Personality Disorder Market Global Industry Analysis and Forecast Till 2025

09-20-2017 04:23 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Borderline Personality Disorder Market Global Industry

Borderline personality disorder (BPD), also known as cluster-B personality disorder, is a neurological health disorder. BPD affects the way a person feels and thinks about oneself and others. Common signs and symptoms of the disorder may include fear of abandonment, self-injuries such as suicidal tendency, intense anger, irritability, dangerous behavior, mood swings, identity disturbance, and chronic feelings of emptiness. Currently, there is no single cause of this disorder. BPD can be caused by a combination of factors such as genes and brain compounds or neurotransmitters. Neurotransmitters are brain chemical messengers that transmit essential information throughout the brain and body.

Request Sample Copy of the Report@

 https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30647

Neurological factors such as estrogen can lead to BPD. Varying estrogen cycles in women make them susceptible to the disorder. Self-injury, depression, and bipolar disorder are major complications of BPD. Borderline personality disorder is diagnosed by a mental health professional through the subject’s history, statistical manual, and procedures. Magnetic resonance imaging (MRI) is a test that uses for borderline personality disorder. Currently, there is no cure for borderline personality disorder; however, a few marketed drugs (antidepressants, mood stabilizers, and antipsychotics) are expected to help improve the symptoms of the disorder. Increasing prevalence of BPD across the globe is expected to drive the global borderline personality disorder market. Additionally, growing global awareness fuels the growth of the market. Multifactorial etiology and complex pathophysiology of the disorder are likely to be major restraints of the market.

The global borderline personality disorder market can be segmented based on treatment, end-user, and region. In terms of treatment, the market can be categorized into psychotherapy and drugs. BPD is primarily treated with psychotherapy. Psychotherapy is also called talk therapy, which is the fundamental treatment approach for this disorder. The primary focus of psychotherapy is to restore the current ability to function, manage emotions, and improve relationships. Psychotherapy can be segmented into dialectical behavior therapy (DBT), mentalization-based therapy (MBT), schema-focused therapy, and transference-focused therapy (TFP) and others. There is no approved drug for BPD; however, certain drugs could help reduce symptoms or co-occurring problems such as anxiety and depression. Drugs could include antipsychotics or mood-stabilizing and antidepressants. In terms of end-user, the borderline personality disorder market can be segmented into psychiatric hospital and home health care. In terms of revenue, the psychiatric hospital segment held a significant share of the market in 2016.

In terms of region, the global borderline personality disorder market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for the largest share of the global borderline personality disorder market in 2016, followed by Europe and Asia Pacific. The U.S. held a major share of the market in North America in terms of revenue. The market in Asia Pacific is expanding rapidly due to increase in number of patients. However, Asia Pacific is projected to be the most attractive market in the near future, especially emerging economies such as India, China, and Japan due to its better health care infrastructure, economic growth, increasing number of insurance payer, expanding and developing private health care sector, and increasing awareness among people.

Key players in the global borderline personality disorder market include Bristol-Myers Squibb, AstraZeneca plc, Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Johnson & Johnson, and Pfizer Inc.

Request TOC of the Report@

 https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30647

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Borderline Personality Disorder Market Global Industry Analysis and Forecast Till 2025 here

News-ID: 730310 • Views:

More Releases from Transparency Market Research

Global Methanol Market to Reach USD 32.9 Billion by 2034, Growing at 3.4% CAGR | Transparency Market Research
Global Methanol Market to Reach USD 32.9 Billion by 2034, Growing at 3.4% CAGR | …
The global methanol market was valued at US$ 22.0 billion in 2023 and is expected to witness steady expansion over the next decade. According to industry analysis, the market is projected to grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2034, reaching an estimated US$ 32.9 billion by the end of 2034. This growth trajectory reflects the increasing relevance of methanol as a versatile chemical
Methanol-to-Olefins Market Poised for Sustainable Growth, Set to Reach USD 44.1 Billion by 2034 at 5.5% CAGR | Transparency Market Research
Methanol-to-Olefins Market Poised for Sustainable Growth, Set to Reach USD 44.1 …
The global Methanol-to-Olefins (MTO) market is witnessing a strong transformation as industries increasingly shift toward sustainable feedstocks and alternative non-petroleum chemical pathways. Valued at US$ 24.5 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2034, reaching an estimated US$ 44.1 billion by the end of 2034. This growth trajectory highlights the strategic importance of MTO technology in
Global Methyl Chloride Market Outlook 2035: Expanding Silicone Demand and Industrial Growth to Propel Market at 5.1% CAGR | Transparency Market Research
Global Methyl Chloride Market Outlook 2035: Expanding Silicone Demand and Indust …
The global methyl chloride market was valued at US$ 2.2 billion in 2023 and is poised for steady expansion over the coming decade. According to the latest industry outlook, the market is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2035, reaching an estimated US$ 4.1 billion by the end of 2035. This sustained growth reflects the compound's critical role as a chemical
Global Methyl Ester Sulfonate Market to Reach USD 974.1 Mn by 2031, Driven by Rising Demand for Biodegradable Surfactants
Global Methyl Ester Sulfonate Market to Reach USD 974.1 Mn by 2031, Driven by Ri …
The global methyl ester sulfonate (MES) market was valued at US$ 656.7 Mn in 2022 and is projected to reach US$ 974.1 Mn by the end of 2031, expanding at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2031. This steady growth trajectory reflects the increasing shift toward biodegradable, plant-based surfactants across personal care, household cleaning, and industrial applications worldwide. Access an overview of significant conclusions from our

All 5 Releases


More Releases for BPD

1 in 10: Uniting for Change - BPD Awareness Week 2025 Calls for Urgent Action
From 1 to 7 October 2025, Australia will mark BPD Awareness Week under the theme "1 in 10: Uniting for Change." This year's campaign carries a clear and urgent message. Recent Australian research reveals that one in ten suicides are linked to symptoms consistent with borderline personality disorder (BPD). This stark statistic highlights the need for urgent reform in mental health care. Despite the risks, people living with BPD continue to
Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis and Market Forecast 2024- …
Introduction Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants requiring prolonged mechanical ventilation or supplemental oxygen. It remains one of the most serious complications of preterm birth, with lasting effects on pulmonary function, growth, and neurodevelopment. The condition not only drives neonatal intensive care unit (NICU) costs but also increases long-term healthcare utilization for affected children. Growing global rates of preterm birth, along with improvements in neonatal
Bronchopulmonary Dysplasia (BPD) Epidemiology Market Analysis
Bronchopulmonary Dysplasia (BPD) represents one of the most significant complications of preterm birth, affecting the respiratory system of premature infants and creating substantial healthcare challenges worldwide. The BPD epidemiology market encompasses therapeutic interventions, diagnostic tools, and supportive care technologies designed to address this chronic lung disease affecting neonates. As medical advances continue to improve survival rates among extremely premature infants, the prevalence of BPD has correspondingly increased, driving demand for
Bipolar Disorder (BPD) Market Segmentation and Analysis Research Report to 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
Bipolar Disorder (BPD) Market Size & Share Analysis & Industry Outlook - 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
Bipolar Disorder (BPD) Market Research Report : : Technologies, Markets and Play …
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at